Draft: 2/8/2017 (Market size: 503.5m, 88,642,000 shares)
Updated: 2/9/2017
Info based on 2016 FR.
Rev: 101m (drop 5.2%)
Op: 32m(drop 11%)
Profit to shareholder: 28.1m (-10%)
CFO: 39m
Total asset: 180m
Liabilities: 28.8m
EBITDA: 38.9m
ROE: 18% (2006-2015: 17~22%)
Dividend: 18.5c=final: 8.5c, special 10c.(2015: 9.5+10.25c)
EPS: 31.77c(2015: 35.45c)
Payout ratio: 58.2% (2015: 55.7%)
At today's price (2/8/2017) 5.69, yield: 3.25%
===============
With revenue goes side line, the yield not attractive, and staff cost increases(or at least under pressure) every year, where is the rosy story for this counter?
Updated: 2/9/2017
Info based on 2016 FR.
Rev: 101m (drop 5.2%)
Op: 32m(drop 11%)
Profit to shareholder: 28.1m (-10%)
CFO: 39m
Total asset: 180m
Liabilities: 28.8m
EBITDA: 38.9m
ROE: 18% (2006-2015: 17~22%)
Dividend: 18.5c=final: 8.5c, special 10c.(2015: 9.5+10.25c)
EPS: 31.77c(2015: 35.45c)
Payout ratio: 58.2% (2015: 55.7%)
At today's price (2/8/2017) 5.69, yield: 3.25%
===============
With revenue goes side line, the yield not attractive, and staff cost increases(or at least under pressure) every year, where is the rosy story for this counter?
This comment has been removed by the author.
ReplyDelete